Delta 9 Cannabis Inc. (DLTNF) Research

Delta 9 Cannabis Inc. is a comprehensive, integrated enterprise within the cannabis sector. Leveraging its subsidiary, Delta 9 Bio-Tech Inc., the company covers the entire vertical spectrum of the cannabis supply chain. This includes everything from cultivation and processing to extraction, wholesale distribution, and ultimately, the retail sale of both medical and recreational cannabis offerings. Its product portfolio encompasses a diverse range of items, including classic dried cannabis flower, convenient pre-rolls, and dried sift, alongside more specialized offerings like decontamination pods. The company also manufactures various oils and other extracted or derivative cannabis products. Beyond consumer products, Delta 9 extends its services to other industry participants, providing grow pods and live cannabis plants to both licensed and pre-licensed businesses. Furthermore, Delta 9 operates a medical clinic, offering physician consultations to patients who require a medical recommendation to obtain a cannabis prescription. Its retail presence is substantial, with 35 stores operating under the "Delta 9" brand across the Canadian Prairies as of April 20, 2022. Established in 2001, Delta 9 Cannabis Inc. maintains its headquarters in Winnipeg, Canada.

Market snapshot

Symbol
DLTNF
Price
$0.01
Day change
-1.95%
Market cap
$1.5M
P/E ratio
-0.05x
52-week range
0.0069-0.02545
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • AusCann Group Holdings Ltd (ACNNF)
  • ATI Physical Therapy, Inc. (ATIP)
  • Pideka Group Inc. (CIMVF)
  • Eve & Co Incorporated (EEVVF)
  • GABY Inc. (GABLF)
  • Heritage Cannabis Holdings Corp. (HERTF)
  • Lumiera Health Inc. (NHPHF)
  • Oxford Cannabinoid Technologies Holdings Plc (OCTHF)

Open Delta 9 Cannabis Inc. (DLTNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.